Participants
Here you will find links to the following institutions that are participating in the ENACT Scheme.
ENACT Participants
The cancers to be investigated in ENACT include Ovarian, Breast, Prostate and Melanoma. Clinical Material will be collected from patients at the five Clinical Centres‡ across Europe over the lifetime of the project. The samples will be subjected to immunological, genomic, biochemical and proteomic analysis using the latest technology.
The partners involved in this study include:
- Nottingham Trent University‡ (Lead Partner)
- The Radium Hospital‡ (Norway)
- The Karolinska Institute‡ (Sweden)
- Institut National de la Sante et de la Recherche medicale‡ (France)
- University of Heidelberg‡ (Germany)
- Medical University of Sofia (Bulgaria)
- University of Tubingen (Germany)
- Jagiellonian University (Poland)
- University of Latvia (Latvia)
- University of Granada (Spain)
- Loreus Ltd (UK)
- St Savas Cancer Hospital (Greece)
- Onyvax Ltd (UK)
[ Back to top ]